Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History RVMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics RVMD

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Revolution Medicines Inc

RVMD
Current price
38.50 USD -0.22 USD (-0.57%)
Last closed 36.44 USD
ISIN US76155X1000
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 7 053 968 896 USD
Yield for 12 month -11.19 %
1Y
3Y
5Y
10Y
15Y
RVMD
21.11.2021 - 28.11.2021

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California. Address: 700 Saginaw Drive, Redwood City, CA, United States, 94063

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

72.91 USD

P/E Ratio

Dividend Yield

Financials RVMD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures RVMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

+11 580 000 USD

Current Quarter

Last Quarter

+261 592 000 USD

Current Year

Last Year

+11 580 000 USD

Current Quarter

Last Quarter

+130 796 000 USD
EBITDA -782 745 024 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -23.09 %
PEG Ratio
Return On Equity TTM -36.68 %
Wall Street Target Price 72.91 USD
Revenue TTM 742 000 USD
Book Value 11.16 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -95.20 %
Dividend Yield
Gross Profit TTM -679 953 024 USD
Earnings per share -4.01 USD
Diluted Eps TTM -4.01 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation RVMD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 8 370.02
Price Sales TTM 9 035.10
Enterprise Value EBITDA -9.71
Price Book MRQ 3.33

Technical Indicators RVMD

For 52 Weeks

29.17 USD 62.40 USD
50 Day MA 39.50 USD
Shares Short Prior Month 18 356 999
200 Day MA 43.24 USD
Short Ratio 11.31
Shares Short 18 157 402
Short Percent 10.37 %